|
Patients (n)
|
12
|
6
| |
|
Age (years)
|
60.8 ± 11.6
|
64.7 ± 1.8
|
0.43
|
|
Female (%)
|
3 (25%)
|
3 (50%)
|
0.31
|
|
Dialysis vintage (years)
|
7.0 ± 4.1
|
14.0 ± 3.5
|
< 0.01
|
|
Antihypertensive drug users (%)
|
10 (83%)
|
5 (83%)
|
1
|
| |
ARB (3)
|
ARB (3)
| |
|
Ca antag. (8)
|
Ca antag. (3)
|
|
β blocker (1)
|
β blocker (2)
|
|
α blocker (0)
|
α blocker (1)
|
|
αβ blocker (1)
|
αβ blocker (0)
|
|
Antiplatelet/anticoagulant users (%)a
|
7 (70%)
|
5 (100%)
|
0.49
|
| |
Aspirin (6)
|
Aspirin (4)
| |
|
Clopidogrel (1)
|
Clopidogrel (0)
|
|
Warfarin (0)
|
Warfarin(0)
|
|
EPA (0)
|
EPA(0)
|
|
O3FAE (0)
|
O3FAE (0)
|
|
Other (1)
|
Other (2)
|
|
Statin (0)
|
Statin (1)
|
|
Ejection fraction (%)a
|
70.2 ± 5.5
|
71.5 ± 5.4
|
0.69
|
|
Comorbidities
|
|
Ischemic heart disease (%)a
|
2 (20%)
|
3 (60%)
|
0.33
|
|
Heart failure (%)a
|
3 (30%)
|
2 (40%)
|
0.85
|
|
Cerebral infarction (%)a
|
1 (10%)
|
2 (40%)
|
0.49
|
|
Cerebral hemorrhage (%)a
|
0 (0%)
|
0 (0%)
|
1
|
|
BMI (kg/m2)
|
25.8 ± 5.1
|
20.7 ± 4.1
|
0.05
|
|
White blood cell count (×103/μL)
|
6.43 ± 1.73
|
6.47 ± 2.16
|
0.91
|
|
Hemoglobin (g/dL)
|
11.5 ± 0.9
|
11.0 ± 0.3
|
0.33
|
|
Platelet (×104/μL)
|
20.5 ± 5.9
|
20.0 ± 4.3
|
0.93
|
|
ESA user (%)
|
67%
|
50%
|
0.86
|
|
Ferritin (ng/mL)
|
77 ± 68
|
205 ± 227
|
0.08
|
|
Sodium (mEq/L)
|
138 ± 2
|
139 ± 2
|
0.37
|
|
Potassium (mEq/L)
|
5.5 ± 0.8
|
4.5 ± 0.9
|
0.02
|
|
Phosphate (mg/dL)
|
6.1 ± 1.6
|
5.3 ± 1.0
|
0.24
|
|
Calcium (mg/dL)
|
9.0 ± 0.7
|
9.4 ± 0.8
|
0.29
|
|
Intact PTH (ng/mL)
|
148 ± 105
|
77 ± 80
|
0.17
|
|
Albumin (g/dL)
|
3.6 ± 0.3
|
3.5 ± 0.2
|
0.55
|
|
Total-cholesterol (mg/dL)
|
168 ± 38
|
175 ± 39
|
0.71
|
|
Triglyceride (mg/dL)
|
127 ± 73
|
95 ± 53
|
0.53
|
|
HDL-cholesterol (mg/dL)
|
38 ± 10
|
56 ± 13
|
< 0.01
|
|
Ankle brachial index (right)
|
1.06 ± 0.25
|
0.94 ± 0.27
|
0.40
|
|
Ankle brachial index (left)
|
1.12 ± 0.17
|
1.10 ± 0.26
|
0.85
|
|
Homocysteine (nmol/mL)
|
32.6 ± 16.0
|
46.4 ± 39.8
|
0.30
|
|
Pentosidine (μg/mL)
|
0.46 ± 0.23
|
0.39 ± 0.19
|
0.54
|
|
hsCRP (mg/dL)
|
0.17 ± 0.17
|
0.34 ± 0.17
|
0.06
|
|
Pentraxin 3 (ng/mL)
|
3.77 ± 1.40
|
5.00 ± 2.08
|
0.15
|
|
Adrenaline (ng/mL)
|
0.018 ± 0.009
|
0.022 ± 0.012
|
0.40
|
|
Noradrenaline (ng/mL)
|
0.34 ± 0.21
|
0.38 ± 0.11
|
0.69
|
|
Dopamine (ng/mL)
|
0.033 ± 0.018
|
0.043 ± 0.021
|
0.26
|
|
Pre-dialysis body weight (kg)
|
74.4 ± 17.1
|
54.0 ± 8.6
|
0.02
|
|
Post-dialysis body weight (kg)
|
71.1 ± 16.1
|
51.2 ± 8.8
|
0.01
|
|
Ultrafiltration volume (ml/session)
|
3604 ± 1234
|
2693 ± 607
|
0.11
|
|
Cardiothoracic ratio (%)
|
51.4 ± 5.1
|
48.3 ± 4.7
|
0.24
|
